Artículos de Interés Recientes

Manual de interpretación 22C3.
Carcinoma de células escamosas de cabeza y cuello

Carcinoma de células escamosas de cabeza y cuello

PD-L1 IHC 22C3 pharmDx is the only companion diagnostic FDA-approved as an aid in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA® (pembrolizumab). This Interpretation Manual is provided as a tool to help guide pathologists and laboratory personnel in achieving correct and reproducible results in assessing PD-L1 expression in FFPE HNSCC specimens.

Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD

Diffuse alveolar damage

An aim of this study was to assess lung autopsy findings in COVID-19 inpatients, and in untreated severe acute respiratory syndrome coron- avirus 2 (SARS-CoV-2)-positive individuals who died in the community…

EURACAN IASLC proposals for updating the histologic classification of pleural mesothelioma towards a more multidisciplinary approach

EURACAN IASLC

PD-L1 IHC 22C3 pharmDx is the only companion diagnostic FDA-approved as an aid in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA® (pembrolizumab). This Interpretation Manual is provided as a tool to help guide pathologists and laboratory personnel in achieving correct and reproducible results in assessing PD-L1 expression in FFPE HNSCC specimens.

info@asopatologiacr.com

8836-3996 I 8362-4295

Heredia

Barva, San José de la Montaña,
Residencial Cypresal, Casa 2.

Será un gusto atender sus inquietudes